Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 318

1.

A study of TB-associated immune reconstitution inflammatory syndrome using the consensus case-definition.

Sharma SK, Dhooria S, Barwad P, Kadhiravan T, Ranjan S, Miglani S, Gupta D.

Indian J Med Res. 2010 Jun;131:804-8.

2.

Clinical characteristics of tuberculosis-associated immune reconstitution inflammatory syndrome in North Indian population of HIV/AIDS patients receiving HAART.

Karmakar S, Sharma SK, Vashishtha R, Sharma A, Ranjan S, Gupta D, Sreenivas V, Sinha S, Biswas A, Gulati V.

Clin Dev Immunol. 2011;2011:239021. doi: 10.1155/2011/239021. Epub 2010 Dec 1.

3.

Urinary lipoarabinomannan as predictor for the tuberculosis immune reconstitution inflammatory syndrome.

Conesa-Botella A, Loembé MM, Manabe YC, Worodria W, Mazakpwe D, Luzinda K, Mayanja-Kizza H, Miri M, Mbabazi O, Koole O, Kestens L, Colebunders R; TB IRIS Group.

J Acquir Immune Defic Syndr. 2011 Dec 15;58(5):463-8. doi: 10.1097/QAI.0b013e31823801de.

PMID:
21963941
4.

Clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome in patients with tuberculosis-HIV coinfection.

Worodria W, Menten J, Massinga-Loembe M, Mazakpwe D, Bagenda D, Koole O, Mayanja-Kizza H, Kestens L, Mugerwa R, Reiss P, Colebunders R; TB-IRIS Study Group.

Antivir Ther. 2012;17(5):841-8. doi: 10.3851/IMP2108. Epub 2012 Apr 27.

PMID:
22543224
5.

Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial.

Laureillard D, Marcy O, Madec Y, Chea S, Chan S, Borand L, Fernandez M, Prak N, Kim C, Dim B, Nerrienet E, Sok T, Delfraissy JF, Goldfeld AE, Blanc FX; CAMELIA (ANRS 1295 – CIPRA KH001) Study Team.

AIDS. 2013 Oct 23;27(16):2577-86. doi: 10.1097/01.aids.0000432456.14099.c7.

PMID:
24096631
6.

Risk factors for 'unmasking immune reconstitution inflammatory syndrome' presentation of tuberculosis following combination antiretroviral therapy initiation in HIV-infected patients.

Valin N, Pacanowski J, Denoeud L, Lacombe K, Lalande V, Fonquernie L, Girard PM, Meynard JL.

AIDS. 2010 Jun 19;24(10):1519-25.

PMID:
20549841
7.

Paradoxical tuberculosis associated immune reconstitution inflammatory syndrome presenting with chylous ascites and chylothorax in a HIV-1 infected child.

Rabie H, Lomp A, Goussard P, Nel E, Cotton M.

J Trop Pediatr. 2010 Oct;56(5):355-8. doi: 10.1093/tropej/fmp141. Epub 2010 Jan 25.

PMID:
20100782
8.

Immune reconstitution inflammatory syndrome among HIV/AIDS patients during highly active antiretroviral therapy in Addis Ababa, Ethiopia.

Huruy K, Mulu A, Mengistu G, Shewa-Amare A, Akalu A, Kassu A, Andargie G, Elias D, Torben W.

Jpn J Infect Dis. 2008 May;61(3):205-9.

9.

Evaluation of paradoxical TB-associated IRIS with the use of standardized case definitions for resource-limited settings.

Eshun-Wilson I, Havers F, Nachega JB, Prozesky HW, Taljaard JJ, Zeier MD, Cotton M, Simon G, Soentjens P.

J Int Assoc Physicians AIDS Care (Chic). 2010 Mar-Apr;9(2):104-8. doi: 10.1177/1545109710361537. Epub 2010 Feb 16.

10.

Clinical characteristics of IRIS syndrome in patients with HIV and tuberculosis.

Michailidis C, Pozniak AL, Mandalia S, Basnayake S, Nelson MR, Gazzard BG.

Antivir Ther. 2005;10(3):417-22.

PMID:
15918332
11.

The immune reconstitution inflammatory syndrome with tuberculosis: a common problem in Ethiopian HIV-infected patients beginning antiretroviral therapy.

Ali K, Klotz SA.

J Int Assoc Physicians AIDS Care (Chic). 2012 May-Jun;11(3):198-202. doi: 10.1177/1545109711402212. Epub 2011 Apr 26.

PMID:
21521804
12.

Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa.

Haddow LJ, Moosa MY, Mosam A, Moodley P, Parboosing R, Easterbrook PJ.

PLoS One. 2012;7(11):e40623. doi: 10.1371/journal.pone.0040623. Epub 2012 Nov 12.

13.

Does immune reconstitution syndrome promote active tuberculosis in patients receiving highly active antiretroviral therapy?

Breen RA, Smith CJ, Cropley I, Johnson MA, Lipman MC.

AIDS. 2005 Jul 22;19(11):1201-6.

PMID:
15990574
14.

Antiretroviral treatment-associated tuberculosis in a prospective cohort of HIV-infected patients starting ART.

Worodria W, Massinga-Loembe M, Mayanja-Kizza H, Namaganda J, Kambugu A, Manabe YC, Kestens L, Colebunders R.

Clin Dev Immunol. 2011;2011:758350. doi: 10.1155/2011/758350. Epub 2010 Dec 8.

15.

Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy.

Shelburne SA, Visnegarwala F, Darcourt J, Graviss EA, Giordano TP, White AC Jr, Hamill RJ.

AIDS. 2005 Mar 4;19(4):399-406.

PMID:
15750393
16.

Treatment for tuberculosis-associated immune reconstitution inflammatory syndrome in 34 HIV-infected patients.

Breton G, Bourgarit A, Pavy S, Bonnet D, Martinez V, Duval X, Longuet P, Abgrall S, Simon A, Leport C; Paradox-TB Study Group.

Int J Tuberc Lung Dis. 2012 Oct;16(10):1365-70. doi: 10.5588/ijtld.11.0693. Erratum in: Int J Tuberc Lung Dis. 2012 Dec;16(12):1712. ANRS-EP21 (Agence Nationale de Recherche sur le Sida) Paradox TB Study Group [corrected to Paradox-TB Study Group]. Int J Tuberc Lung Dis. 2014 Jun;18(6):754. Elmarsafy, S [corrected to El Marsafy, S].

PMID:
23107635
17.

The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial.

Naidoo K, Yende-Zuma N, Padayatchi N, Naidoo K, Jithoo N, Nair G, Bamber S, Gengiah S, El-Sadr WM, Friedland G, Abdool Karim S.

Ann Intern Med. 2012 Sep 4;157(5):313-24. doi: 10.7326/0003-4819-157-5-201209040-00004.

18.

The impact of HAART initiation timing on HIV-TB co-infected patients, a retrospective cohort study.

Yang CH, Chen KJ, Tsai JJ, Lin YH, Cheng SH, Wang KF, Chiou HY.

BMC Infect Dis. 2014 Jun 4;14:304. doi: 10.1186/1471-2334-14-304.

19.

Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy.

Elliott JH, Vohith K, Saramony S, Savuth C, Dara C, Sarim C, Huffam S, Oelrichs R, Sophea P, Saphonn V, Kaldor J, Cooper DA, Chhi Vun M, French MA.

J Infect Dis. 2009 Dec 1;200(11):1736-45. doi: 10.1086/644784.

PMID:
19874177
20.

[Tuberculosis-associated immune reconstitution inflammatory syndrome].

Leone S, Nicastri E, Giglio S, Corpolongo A, Narciso P, Acone N.

Infez Med. 2008 Dec;16(4):193-9. Review. Italian.

Supplemental Content

Support Center